MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
NBIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Neurocrine Biosciences (NBIX) Ownership - Who owns Neurocrine Biosciences?

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
6027 Edgewood Bend Court
Phone
+1 858 617-7600
Employees
2000
Web
https://www.neurocrine.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
15.55B
P/E Ratio
22.36
Total Cash
389.8M
Projected Growth
0.45
Total Debt
401.8M
Revenue
3.37B
Risk (Beta)
0.56
Dividend Yield
N/A
Total Cash/Share
3.83
Total Debt/Equity
N/A
Revenue/Share
32.60 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
NBIX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for NBIX
A.I. Advisor
published General Information

General Information

a product based biopharmaceutical company

Industry PharmaceuticalsGeneric

Profile
Details
Industry
Biotechnology
Address
6027 Edgewood Bend Court
Phone
+1 858 617-7600
Employees
2000
Web
https://www.neurocrine.com
Who owns Neurocrine Biosciences? NBIX symbol Ownership - Tickeron.com